Continued elimination of measles, rubella and congenital rubella syndrome in the United States, January 2022-June 2024

Vaccine. 2025 Feb 6:46:126678. doi: 10.1016/j.vaccine.2024.126678. Epub 2025 Jan 3.

Authors

Thomas D Filardo¹, Adria D Mathis², Kelley Raines², Stephen N Crooke², R Suzanne Beard², Jessica Prince-Guerra², Paul A Rota², David E Sugerman²

Affiliations

¹ Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rhx1@cdc.gov.
² Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

No abstract available

Keywords: Congenital rubella syndrome; Elimination; Measles; Rubella; United States of America; Vaccination.

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States